Short Squeeze Setup — velZ +0.30 · age 15w×1.00 · 24.64%
Founder-Led — founder/CEO led
About Q32 Bio Inc
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human anti"interleukin-7 receptor alpha antagonist monoclonal antibody which completed Phase 2a clinical trials, designed to re-regulate adaptive immune func… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: March 28, 2018
Headquarters: 830 Winter Street, Waltham, MA, United States, 02451
Founder-Led: Yes — Shelia Violette (Co-founder, Chief Scientific Officer & President of Research)
Key Metrics
Current Price
$8.34
Market Cap
$241M
Float
14.6M
Shares Outstanding
29.8M
P/E (TTM)
2.54
Price/Sales (TTM)
4.48
vs. Analyst Target
+374.8% to analyst PT
Profit Margin
62.87%
Operating Margin (TTM)
39.94%
Revenue (TTM)
$53.7M
Dividend Rate
None
Analyst Target Price
$39.60 (6 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$2.7M
-$129M
$2.7M
-$120M
2021
$34.0M
-$95.8M
$24.4M
-$86.2M
2022
$3.2M
-$42.8M
$609,000
-$38.9M
2023
-$6.7M
-$53.7M
-$7.2M
-$47.8M
2024
N/A
-$47.7M
-$487,000
-$45.3M
2025
$53.7M
$29.8M
$53.3M
$31.3M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Sep 2025
N/A
-$7.4M
Dec 2025
$53.7M
$57.7M
Mar 2026
N/A
-$7.6M
Jun 2026
N/A
N/A
Ownership & Float
Insider Ownership
2.1%
Institutional Ownership
80.7%
Short Float
24.3%
% of All Funds Holding
0.82%
Number of Funds Holding
72
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$12.07
Near-term / short-term trend
Weekly
40-Week SMA
$8.92
Medium-term trend
Weekly
80-Week SMA
$5.54
Cyclical trend (business cycle)
Weekly
200-Week SMA
$14.69
Secular trend (multi-year)
Monthly
10-Month SMA
$9.14
Near-term monthly trend
Monthly
20-Month SMA
$5.61
Medium-term monthly trend
Monthly
40-Month SMA
$13.61
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$5.60
support
1.14x
4 months ago
$1.50
support
6.39x
14 months ago
$27.00
resistance
4.99x
21 months ago
$47.00
resistance
1.42x
22 months ago
Historical Earnings Reactions (34 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.41%
0.00%
47.06%
11.94%
-6.73%
1 Day
-0.60%
-0.10%
44.12%
15.36%
-20.26%
1 Week
-0.43%
-0.26%
50.00%
35.46%
-45.98%
2 Weeks
1.14%
1.14%
55.88%
72.85%
-48.27%
1 Month
5.18%
3.52%
54.55%
134.05%
-87.46%
Next earnings: November 12, 2026 (32 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
2.0%
62.5%
8
Feb
7.1%
50.0%
8
Mar
-6.2%
25.0%
8
Apr
-8.2%
22.2%
9
May
11.2%
55.6%
9
Jun
1.2%
55.6%
9
Jul
22.4%
55.6%
9
Aug
-2.7%
44.4%
9
Sep
-1.8%
55.6%
9
Oct
-5.5%
25.0%
8
Nov
-11.3%
37.5%
8
Dec
-2.7%
62.5%
8
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
0.43%
45.7%
403
Tuesday
0.07%
46.5%
441
Wednesday
-0.19%
44.4%
437
Thursday
0.20%
48.0%
431
Friday
-0.22%
46.4%
429
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 80.7%
Insider Transactions — Smart Summary
Total insider ownership: 2.1%
Founder-led management: Shelia Violette (Co-founder, Chief Scientific Officer & President of Research)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Q32 Bio Inc
(QTTB) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.